ACPU
ONCE

Arrowgrass Capital Partners (US)’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History

Arrowgrass Capital Partners (US)’s Portfolio ONCE Stock Details ONCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-2,255
Closed -$231K – 337
2019
Q2 		$231K Buy
+2,255
New +$243K 0.01% 335

Other funds holding ONCE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

Arrowgrass Capital Partners (US)'s ONCE Position: Q3 2019 in Review

Arrowgrass Capital Partners (US) sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q3 2019, closing a stake of 2,255 shares — an estimated $231K sold.

Arrowgrass Capital Partners (US) first reported a position in ONCE in Q2 2019 and held it in 1 quarter. The position peaked at $231K in Q2 2019. 184 funds tracked by Wall St. Rank hold ONCE as of Q3 2019.

  • Arrowgrass Capital Partners (US) reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q3 2019 after selling out during the quarter.
  • Arrowgrass Capital Partners (US) sold 2,255 Spark Therapeutics, Inc. Common Stock shares in Q3 2019, an estimated $231K.
  • Arrowgrass Capital Partners (US) first reported a position in Spark Therapeutics, Inc. Common Stock in Q2 2019 and held it in 1 quarter.
  • Arrowgrass Capital Partners (US)'s Spark Therapeutics, Inc. Common Stock position peaked at $231K in Q2 2019.
  • 184 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q3 2019.

Based on Arrowgrass Capital Partners (US)'s 13F filing for Q3 2019, filed 14 Nov 2019.